Cellectar Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Cellectar Biosciences, Inc. (CLRB) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $21.30 per share as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-03-04
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $21.30.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $65.70; Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed $2.19.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $1.81.
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $2.31.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2025-12-31 | $21.30 10-K · filed 2026-03-04 | |
| 2024-12-31 | $65.70 10-K · filed 2026-03-04 | $2.19 10-K · filed 2025-03-13 |
| 2023-12-31 | $1.81 10-K · filed 2025-03-13 | |
| 2023-03-31 | $2.31 10-Q · filed 2023-05-04 | |
| 2023-01-01 | $5.25 10-K · filed 2024-03-27 | |
| 2022-12-31 | $5.25 10-K/A · filed 2024-10-29 | |
| 2022-09-30 | $6.14 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $6.20 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $0.68 10-Q · filed 2023-05-04 | |
| 2022-01-01 | $3.20 10-K · filed 2024-03-27 | |
| 2021-12-31 | $9.80 10-K · filed 2023-03-09 | $0.98 10-K · filed 2022-03-21 |
| 2021-09-30 | $9.20 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $9.20 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $1.38 10-Q · filed 2022-05-10 | |
| 2021-01-01 | $14.40 10-K · filed 2023-03-09 | $1.44 10-K · filed 2022-03-21 |
| 2020-12-31 | $1.44 10-K · filed 2022-03-21 | |
| 2020-01-01 | $1.82 10-K · filed 2022-03-21 | |
| 2019-12-31 | $1.82 10-K · filed 2021-03-02 | |
| 2019-01-01 | $4.14 10-K · filed 2021-03-02 | |
| 2018-12-31 | $4.10 10-K · filed 2020-03-09 | |
| 2017-12-31 | $29.13 10-K · filed 2020-03-09 | $2.91 10-K · filed 2018-03-21 |
| 2016-12-31 | $32.70 10-K · filed 2019-02-26 | $3.27 10-K · filed 2017-03-15 |
| 2016-09-30 | $3.19 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $3.21 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $23.39 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $23.93 10-K · filed 2018-03-21 | $23.90 10-K · filed 2016-03-11 |
| 2015-03-31 | $4.35 10-Q · filed 2015-05-20 | |
| 2014-12-31 | $49.52 10-K · filed 2017-03-15 | $4.67 10-K · filed 2015-03-24 |
| 2013-12-31 | $65.99 10-K/A · filed 2016-10-20 | $6.60 10-K · filed 2015-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |